Systemic Anticancer Therapy at the End of Life—Changes in Usage Pattern in the Immunotherapy Era
Maureen Canavan, Xiaoliang Wang, Mustafa Ascha, Rebecca A. Miksad, Gregory S. Calip, Cary P. Gross, Kerin B. Adelson
Abstract
This cohort study evaluates the rate of systemic anticancer therapy use among patients dying of cancer.
Topics & Concepts
MedicineImmunotherapyMEDLINEOncologyInternal medicineIntensive care medicineCancerLawPolitical sciencePalliative Care and End-of-Life IssuesEconomic and Financial Impacts of CancerChildhood Cancer Survivors' Quality of Life